akhatri

MHRA Class 4 Medicines Notification: Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension (Cross Healthcare Limited) Drug alert number: EL(25)A/12 Date issued: 31 March 2025 Cross Healthcare Limited has informed the MHRA that there is a printing defect on the outer labels for the Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, [...]

The post MHRA Class 4 Medicines Notification: Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension (Cross Healthcare Limited) appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Megestrol (Megace®) 160mg tablets MSN/2025/016 Tier 2 – medium impact Date of issue: 25/03/2025 Megestrol (Megace®) 160mg tablets are out of stock until mid-April 2025. Medroxyprogesterone (Provera®) 200mg and 400mg tablets remain available and can support an increase in demand. Medroxyprogesterone [...]

The post Medicine Supply Notification: Megestrol (Megace®) 160mg tablets appeared first on Community Pharmacy England.

Community pharmacy teams are reminded that, from 6 April 2025, patients who hold a tax credit exemption certificate will no longer receive automatic entitlement to free NHS prescriptions under the ‘Tax Credit exemption certificate’ category. This is because HM Revenue & Customs (HMRC) will be ending tax credit payments on 5 April 2025. To help [...]

The post Tax credits are ending – downloadable poster for pharmacies to display appeared first on Community Pharmacy England.

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued guidance regarding the use of prolonged-release opioids in post-operative pain. The indication for the treatment of post-operative pain has been removed from the licences of all prolonged release opioids including prolonged-release morphine and prolonged-release oxycodone, due to the increased risk of persistent post-operative opioid use [...]

The post MHRA Drug Safety Update: Use of prolonged-release opioids in post-operative pain appeared first on Community Pharmacy England.

This recall notification has been updated since its initial publication on 11 March 2025 to include the correct information in relation to the safety updates in the Patient Information Leaflet (PIL) and the changes that have been made in line with reference product PIL. MHRA Class 4 Medicines Notification: Azithromycin 250 mg Capsules (Jubilant Pharmaceuticals [...]

The post Update – MHRA Class 4 Medicines Defect Notification: Azithromycin 250 mg Capsules (Jubilant Pharmaceuticals NV) appeared first on Community Pharmacy England.